⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13163781 | 1.00 | — | — | |
| SCHEMBL11111449 | 1.00 | — | — | |
| SCHEMBL19934701 | 0.91 | BMP1 (0.46) | — | |
| SCHEMBL21153275 | 0.91 | BMP1 (0.46) | — | |
| SCHEMBL19934696 | 0.91 | BMP1 (0.46) | — | |
| SCHEMBL19934754 | 0.91 | BMP1 (0.46) | — | |
| SCHEMBL21134710 | 0.91 | BMP1 (0.46) | — | |
| SCHEMBL21135087 | 0.91 | BMP1 (0.46) | — | |
| SCHEMBL19934743 | 0.91 | BMP1 (0.46) | — | |
| SCHEMBL19934735 | 0.91 | BMP1 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2981282-B1 | GROWTH HORMONE COMPOUND FORMULATION | NOVO NORDISK HEALTHCARE AG (CH) | 2020-11-04 | — | — | EP | disclosed |
| EP-2525834-B1 | GROWTH HORMONES WITH PROLONGED IN-VIVO EFFICACY | NOVO NORDISK HEALTHCARE AG (CH) | 2019-07-17 | — | — | EP | disclosed |
| US-8865126-B2 | Vitamin-targeted imaging agents | ENDOCYTE, INC. (US) | 2014-10-21 | — | — | US | disclosed |
| US-8834842-B2 | Vitamin-targeted imaging agents | ENDOCYTE, INC. (US) | 2014-09-16 | — | — | US | disclosed |
| US-20140065068-A1 | VITAMIN-TARGETED IMAGING AGENTS | ENDOCYTE, INC. (US) | 2014-03-06 | — | — | US | disclosed |
| EP-2280734-B1 | FACTOR IX CONJUGATES WITH EXTENDED HALF-LIVES | CANTAB BIOPHARMACEUTICALS PATENTS LTD (MT) | 2014-02-26 | — | — | EP | disclosed |
| US-20130237687-A1 | VITAMIN-TARGETED IMAGING AGENTS | ENDOCYTE, INC. (US) | 2013-09-12 | — | — | US | disclosed |
| WO-2012010516-A1 | GROWTH HORMONE CONJUGATES | NOVO NORDISK HEALTH CARE AG (CH) | 2012-01-26 | — | — | WO | disclosed |
| US-20110183906-A1 | FACTOR IX CONJUGATES WITH EXTENDED HALF-LIVES | CELTIC PHARMA PEG LTD. (GB) | 2011-07-28 | — | — | US | disclosed |
| US-20100249027-A1 | CRF CONJUGATES WITH EXTENDED HALF-LIVES | HENRY WILLIAM | 2010-09-30 | — | — | US | disclosed |
| US-20100222546-A1 | METHODS FOR THE PREPARATION OF FUNCTIONALIZED PEPTIDES, PROTEINS AND CARBOHYDRATES AND THEIR CONJUGATES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-09-02 | — | — | US | disclosed |
| WO-2010057962-A2 | CRF CONJUGATES WITH EXTENDED HALF-LIVES | NEUTRON LIMITED (BM) | 2010-05-27 | — | — | WO | disclosed |